Veterans Affairs



Update 1/5/2021 Evidence SynthesisNo updatesMedication Collaboratory (Alexandra)Review meeting today.Aim to award planning funds to develop more complete proposals. Separate Coordinating Center/Methods activity from Long Term Outcomes project. Will need to coordinate long-term outcomes project with NIH and FDA. Remdesivir analysis will be presented to Methods WG this week. Question from Congress about Fluvoxamine. Non COVID Impacts: (Stephanie)Solicitation for a Data Core/Coordinating Center + Concept papers for individual projects to be released next Monday; due mid-February.F/U research on COVID Vaccine (Miho/Maciej)QUERI teams actively working at three sites. Proposals for longer research due Jan 21Modeling and COVID (Miho) Discussion with Kameron Mathews and NCP decided to defer briefing with EIC, explicit use of models. May still be value once we hit 1c recommendation group where supply << priority group. Revised MS ready for submission to JAMA NetworkWe’ve asked teams to examine a few questions about change in risk factors over course of epidemic – e.g. is race/ethnicity still a risk factor for infection as pandemic has progressed to different regions? Phase 4 Vaccine StudiesMeeting planned with Vicky and Maciej to discuss path for developing CSP-type study that would be aligned with other national efforts (FDA, NIH, CDC)Dawn Provenzale developing concept proposal for consideration at Vickie’s request. We have priorities from Fran Cunningham in PBM. Maciej assisting. NOTE: Resources not yet identified for this (was it in OWS request?)CLCs: Question from Michael Gelman about use of rapid antigen testing for CLC staff screening. Propose we develop a research project to compare screening approaches (e.g. Ag vs. PCR)Disparities: No updatesData: No updateRegistry: No update ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download